American Bio Medica Corporation  

(Public, OTCMKTS:ABMC)   Watch this stock  
Find more results for Milissa Bailey�
0.000 (0.00%)
Apr 16 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.07 - 0.19
Open     -
Vol / Avg. 0.00/20,763.00
Mkt cap 2.98M
P/E     -
Div/yield     -
EPS -0.07
Shares 22.96M
Beta 0.77
Inst. own 2%
Mar 24, 2014
Q4 2013 American Bio Medica Corporation Earnings Release (Estimated)

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -9.44% -11.89%
Operating margin -12.67% -9.94%
EBITD margin - -8.63%
Return on average assets -17.45% -21.33%
Return on average equity -95.51% -59.51%
Employees 79 -
CDP Score - -


122 Smith Road
United States - Map
+1-518-7588158 (Phone)
+1-518-7588171 (Fax)

Website links


American Bio Medica Corporation develops, manufactures and sells immunoassay tests for the immediate, point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. The Company�s DOA testing products offer employers, law enforcement, government, health care, laboratory and education professionals, self-contained products capable of identifying illicit drug use within minutes. In addition to the manufacture and sale of DOA testing products, it provides bulk test strip contract manufacturing services for other POCT companies.

Officers and directors

Edmund M. Jaskiewicz Chairman of the Board, President
Age: 89
Melissa A. Waterhouse Interim Chief Executive Officer and Chief Financial Officer
Age: 43
Todd Bailey Vice President - Sales and Marketing
Age: 42
J. Duncan Urquhart Controller
Age: 59
Jean Neff Treasurer, Corporate Secretary, Director
Age: 70
Carl A. Florio Independent Director
Age: 64
Richard P. Koskey Independent Director
Age: 73